Can I read Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts on EtoBox?

Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts by Avik Chatterjee; Michelle Weitz; Alexandra Savinkina; Alexandria Macmadu; R. W. M. A. Madushani; Ruth A. Potee; Danielle Ryan; Sean M. Murphy; Alexander Y. Walley; Benjamin P. Linas is a Medicine article available to read on EtoBox.

What is Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts about?

## Key Points ## Question Is provision of medications for opioid use disorder (MOUD) during incarceration associated with fewer overdose deaths? ## Findings This economic evaluation of a model of the natural history of OUD in Massachusetts found that a strategy offering buprenorphine, methadone, and naltrexone during incarceration was associated with 192 fewer overdose deaths (a 1.8% reduction) and was less costly than a naltrexone-only strategy averting 95 overdose deaths (a 0.9% reduction). The 3-MOUD strategy was also cost-effective at $7252 per quality-adjusted life-year gained. ## Meaning These findings suggest that offering 3 MOUDs during incarceration is a life-saving, cost-effective intervention.

Who reads Estimated Costs and Outcomes Associated With Use and Nonuse of Medications for Opioid Use Disorder During Incarceration and at Release in Massachusetts?

Author

Avik Chatterjee; Michelle Weitz; Alexandra Savinkina; Alexandria Macmadu; R. W. M. A. Madushani; Ruth A. Potee; Danielle Ryan; Sean M. Murphy; Alexander Y. Walley; Benjamin P. Linas

Publisher

American Medical Association (AMA)

Published

2023

Language

EN

Field

Medicine (Health Sciences)